Vaksinasi COVID-19 dan Kesehatan Mata

Mohammad Alif Azizi, Jodii Arlan Kurnia


Vaksinasi COVID-19 secara massal berisiko efek samping, di antaranya efek samping pada mata. Data VAERS hingga tanggal 13 Februari 2021, melaporkan 46 laporan kasus efek samping pada okular dan adneksa. Manifestasi pada mata setelah pemberian vaksin COVID-19 relatif ringan dan sementara. Sampai saat ini, tidak ada bukti yang mendukung bahwa individu harus menghindari vaksinasi COVID-19 untuk alasan kesehatan mata.

The global use of COVID-19 vaccine carries risks of side effects, including side effects on the eyes. Until 13 February 2021, VAERS reported 46 cases of side effects on the ocular and adnexa. The eye side effects of COVID-19 vaccine are relatively mild and transient. There is no statistical evidence to suggest that COVID-19 vaccination should be avoided for reasons related to eye health.

Full Text:



Saleh A, Qamar S, Tekin A, Singh R, Kashyap R. Vaccine development throughout history. Cureus 2021;13(7):e16635. doi:10.7759/cureus.16635.

McNeil M, DeStefano F. Vaccine-associated hypersensitivity. J Allerg Clin Immunol. 2018;141(2):463-72.

Kim J, Marks F, Clemens J. Looking beyond COVID-19 vaccine phase 3 trials. Nature Med. 2021;27(2):205-11.

Wouters O, Shadlen K, Salcher-Konrad M, Pollard A, Larson H, Teerawattananon Y, et al. Challenges in ensuring global access to COVID-19 vaccines: Production, affordability, allocation, and deployment. Lancet 2021;397(10278):1023-34.

Sundaram A, Ewing D, Liang Z, Jani V, Cheng Y, Sun P, et al. Immunogenicity of adjuvanted psoralen-inactivated SARS-CoV-2 vaccines and SARS-CoV-2 spike protein DNA vaccines in BALB/c Mice. Pathogens 2021;10(5):626.

Deng Y, Lan J, Bao L, Huang B, Ye F, Chen Y, et al. Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus. Emerg Microbes Infect. 2018;7(1):60.

Han X, Xu P, Ye Q. Analysis of COVID-19 vaccines: Types, thoughts, and application. J Clin Lab Anal. 2021;35(9):e23937. doi:10.1002/jcla.23937

Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, et al. An mRNA vaccine against SARS-CoV-2 - Preliminary report. N Engl J Med. 2020;383(20):1920-31

Al Khames Aga QA, Alkhaffaf WH, Hatem TH, Nassir KF, Batineh Y, Dahham AT, et al. Safety of COVID-19 vaccines. J Med Virol. 2021;93(12):6588-94.

Cheng J, Margo C. Ocular adverse events following vaccination: overview and update. Survey Ophthalmol. 2021;Apr 16:S0039-6257(21)00099-0. doi: 10.1016/j.survophthal.2021.04.001.

Shimabukuro T, Cole M, Su J. Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US—December 14, 2020-January 18, 2021. JAMA.2021;325(11):1101.

Laisuan W, Wongsa C, Chiewchalermsri C, Thongngarm T, Rerkpattanapipat T, Iamrahong P, et al. CoronaVac COVID-19 vaccine-Induced anaphylaxis: Clinical characteristics and revaccination outcomes. J Asthma Allerg. 2021;14:1209-15.

Austria Q, Lelli G, Segal K, Godfrey K. Transient eyelid edema following COVID-19 vaccination. Ophthalmic Plastic & Reconstructive Surg. 2021;37(5):501-2.

Honavar S, Sen M. After the storm: Ophthalmic manifestations of COVID-19 vaccines. Indian J Ophthalmol. 2021;69(12):3398.

Goyal M, Murthy SI, Annum S. Bilateral multifocal choroiditis following COVID-19 vaccination. Ocul Immunol Inflamm. 2021;29(4):753-7. doi:10.1080/09273948.2021.1957123.

Ng XL, Betzler BK, Testi I, Ho SL, Tien M, Ngo WK, et al. Ocular adverse events after COVID-19 vaccination. Ocul Immunol Inflamm. 2021;29(6):1216-24. doi:10.1080/09273948.2021.1976221

Papasavvas I, Herbort C. Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination. J Ophthalmic Inflammation and Infection. 2021;11(1):21.

Subramony R, Lin LC, Knight DK, Aminlari A, Belovarski I. Bilateral retinal detachments in a healthy 22-year-old woman after Moderna SARS-COV-2 vaccination. J Emerg Med. 2021;61(6):146-50. doi:10.1016/j.jemermed.2021.07.034

Fowler N, Mendez Martinez NR, Pallares BV, Maldonado RS. Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine. Am J Ophthalmol Case Rep. 2021;23:101136. doi:10.1016/j.ajoc.2021.101136 l

Helmchen C, Buttler GM, Markewitz R, Hummel K, Wiendl H, Boppel T. Acute bilateral optic/chiasm neuritis with longitudinal extensive transverse myelitis in longstanding stable multiple sclerosis following vector-based vaccination against the SARS-CoV-2. J Neurol. 2022;269(1):49-54. doi:10.1007/s00415-021-10647-x 1.

Reyes-Capo D, Stevens S, Cavuoto K. Acute abducens nerve palsy following COVID-19 vaccination. J Am Assoc Pediatr Ophthalmol Strabismus. 2021;25(5):302-3.

Rubinstein TJ. Thyroid eye disease following COVID-19 vaccine in a patient with a history Graves’ disease: A case report. Ophthalmic Plast Reconstr Surg. 2021;37(6):221-3. doi:10.1097/IOP.0000000000002059


  • There are currently no refbacks.